A 20% price drop on a single day following an earnings release, and a 30% loss in just five trading days is an unusual event for a large cap company, even in the biotech sector.
Celgene (CELG) has shocked investors when it published Q3 results, issued a more conservative guidance for 2017 and lowered the mid-term outlook for the year 2020.
Source: Celgene Q3 earnings release.
Einhorn, Barbarito, Frost & Botwinick, PC, is pleased to announce that Matthew S. Rheingold has been elevated from
Einhorn, Barbarito, Frost & Botwinick, PC, is pleased to announce that partners Thomas J. Snyder and Matheu D. Nunn
Mark H. Anania, a partner at McCarter & English, LLP, has been named President of the New Jersey Intellectual Property Law Association
Cohen Seglias Pallas Greenhall & Furman PC is pleased to announce that Anthony H. Chwastyk has joined the
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2024 citybuzz
